ch7

Chapter Outline

Definition: Drug resistance is a phenomenon where a drug that was initially effective in inhibiting or destroying target organisms becomes ineffective. This can arise due to various biological mechanisms.
Types of Resistance:
- Natural (Intrinsic) Resistance: Some organisms have inherent characteristics that make them resistant to certain drugs. For instance, certain bacteria possess cell wall structures that are impermeable to specific antibiotics.
- Acquired Resistance: This occurs when organisms that were once sensitive develop resistance through genetic mutations or acquiring resistance genes from other organisms.
Examples: In a microbial colony, a small fraction may harbor mutations that confer resistance, leading these organisms to proliferate once the susceptible ones are eliminated by the drug.
Significance: Resistance highlights the genetic adaptability of microorganisms and cancer cells, presenting significant challenges in treatment efficacy.
Distinction between Resistance and Tolerance:
- Resistance: The organism becomes completely unresponsive to the drug.
- Tolerance: The organism continues to respond but requires higher doses to achieve the same therapeutic effect. This is commonly observed in cases such as morphine addiction, where increasing doses are needed over time to attain the same analgesic effect.

There are multiple mechanisms through which organisms evaded the effects of drugs, complicating treatment strategies and necessitating new approaches.

Mechanism: Mutations in target proteins can lead to structural changes that reduce a drug’s ability to bind effectively.
Example: The resistance to trimethoprim in bacteria can be caused by a single amino acid mutation in the dihydrofolate reductase enzyme, modifying the binding affinity of the drug.

Mechanism: Cells may increase the production of targeted enzymes or receptors, allowing them to survive in the presence of the drug.
Example: Many cancer cells may elevate levels of kinases to counteract the effects of kinase inhibitors.

Mechanism: Increased concentrations of substrates can lead to competition that hampers drug action.
Example: Augmented levels of p-aminobenzoic acid can negatively impact the efficacy of sulfonamide antibiotics.

Mechanism: Organisms may enhance their ability to metabolize or destroy drugs through mechanisms like enzyme induction.
Example: Production of β-lactamases by bacteria is a well-known method to degrade penicillin and thereby confer resistance.

Mechanism: In some cases, organisms may remove or inactivate the enzymes required to convert prodrugs into their active forms, blocking therapeutic effects.

Mechanism: By activating alternative metabolic pathways, organisms can bypass the mechanisms targeted by the drug.

Mechanism: Some pathogens can upregulate enzymes that repair drug-induced damage, effectively reversing the drug’s intended effects.

Mechanism: Modifications in cellular drug permeability or increased drug efflux can hinder the concentration of the drug at target sites, reducing therapeutic efficacy.

Definition: Drug synergism is a pharmacological phenomenon wherein the combined effects of two or more drugs are greater than the sum of their individual effects when administered separately, leading to enhanced therapeutic outcomes.

Mechanism: Administering an enzyme inhibitor along with a drug can enhance its effectiveness by preventing its degradation.
Example: The combination of β-lactamase inhibitors with penicillin antibiotics is a classic example where inhibitors protect the antibiotic from being broken down by bacterial enzymes.

Mechanism: The simultaneous inhibition of successive steps in metabolic or signaling pathways can provide a comprehensive blockade against disease processes, enhancing overall treatment effectiveness.
Example: The combination of sulfadoxine and pyrimethamine is utilized in malaria therapy, targeting different stages of the parasite lifecycle.

Mechanism: Concurrent targeting of multiple pathways can effectively overcome various resistance mechanisms and improve drug efficacy.

Mechanism: Inhibiting efflux pumps in bacterial or cancer cells can lead to increased retention of drugs within the cells, enhancing their efficacy.

Mechanism: Administering various drugs that target the same enzyme can counteract the effects of resistance by addressing different mutations and pathways, thereby maintaining therapeutic effectiveness.